期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新生血管性年龄相关性黄斑变性的治疗进展 被引量：10

Recent advances on treatment for neovascular age-related macular degeneration
下载PDF
导出
摘要 年龄相关性黄斑变性(age-related macular degeneration,AMD)已是当今世界上老年人的主要致盲原因之一,且随着人类平均寿命的延长,人口老龄化,此病也有日益增多的趋势。近年来,对AMD尤其是新生血管性AMD的治疗已经进行了大量的多中心的临床试验观察,涌现出激光光凝、经瞳孔温热疗法、光动力疗法、药物治疗、手术治疗、放射治疗、基因治疗等方法。本文就新生血管性AMD目前的治疗方法及其研究进展做一综述。 Age-related macular degeneration （AMD） is a major reason for blindness of elder people in the world. With the increasing of average human life and population senescence, AMD has a tendency to increase. In recent years, treatments for AMD, especially for neovascular AMD have taken lots of multicenter clinical studies, as laser photocoagulation, transpupillary thermotherapy, drug treatment, surgery treatment, laser treatment and gene treatment. This article reviews treatments for and research advances on neovascular AMD.
作者 李岱 李青春 孙明
机构地区 咸宁学院眼科学教研室
出处 《眼科新进展》 CAS 北大核心 2010年第8期797-800,共4页 Recent Advances in Ophthalmology
基金 湖北省科技厅基金资助(编号:2007ABA380) 湖北省卫生厅青年科技人才项目基金资助(编号:QJX2008-37)~~
关键词 年龄相关性黄斑变性 脉络膜新生血管 激光光凝 经瞳孔温热疗法 光动力疗法 age-related macular-degeneration choroidal neovascularizaiton laser photocoagulation transpupillary thermotherapy photodynamic therapy
分类号 R774 [医药卫生—眼科]
  • 相关文献

参考文献24

  • 1Virgili G,Bini A. Laser photocoagulation for neovascular age-related macular degeneration[ J]. Cochrane Database Syst Rev ,2007, 18(3) : CD004763.
  • 2Kuo HK,Kao MT,Chen YJ,Chen CH, Wu PC,Kao ML. Transpupillary thermotherapy in chinese patients with choroidal neovasculaxization secondary to age-related macular degeneration:emphasis on the influence of power setting[ J ]. Ophthalmologica, 2008,222 (2) :117-122.
  • 3Odergren A, Algvere PV, Seregard S, Kvanta AA. A prospective randomized study on low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration[ J].Br J Ophthalmol,2008,92(6) :757-761.
  • 4Potter MJ, Szabo SM. Recurrence of choroidal neovascularization after photodynamic therapy in patients with age-related macular degeneration[ J]. Dr J Ophthalmol,2007,91 (6) :753- 756.
  • 5Tsuchiya D, Yamamoto T, Kawasaki R, Yamashita H. Two-year visual outcomes afar photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions[ J]. Retina ,2009,29(7 ) :960-965.
  • 6Maier MM, Feucht N,Fiore B, Winkler von Mohrenfels C,Kook P,Fegert C, et al. Photodynamic therapy with verteporfin combined with intravitreal injection of ranibizumab for occult and classic CNV in AMD [ J ]. Klin Monbl Augenheilkd, 2009,226 (6) :496-502.
  • 7牛彤彤,徐艳春.VEGF与眼内血管新生[J].眼科新进展,2008,28(5):394-398. 被引量：11
  • 8Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer( EYE001 )for the treatment of exudative age-related macular degeneration [ J ]. Retina,2002,22 (2) :143-152.
  • 9Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to agerelated macular degeneration: phase Ⅱ study results [ J ]. Ophthalmology ,2003,110 ( 5 ) :979-986.
  • 10Gragoudas ES,Adamis AP, Cmmingham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration[ J ]. N Engl J Med, 2004,351 ( 27 ) : 2805- 2816.

二级参考文献61

  • 1Muller YA, Chen Y, Christinger HW, Li B, Ctmningham BC, Lowman HB, et al. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface [ J ]. Structure 1998 ;6(9) :1153-1167.
  • 2Fernando NH, Hurwitz HI. Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer[ J ]. Semin Oncol 2003 ;30 ( suppl 5 ) :39-50.
  • 3Sweeney C J, Miller KD, Sissons SE, Nozaki S, Hoilman DK, Shen J, et al. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors[ J ]. Cancer Res 2001 ;61 (8) : 3369-3372.
  • 4Michels S, Rosenfeld PJ, Puliafito CA. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study[J]. Ophthalmology 2005 ; 112 ( 6 ) : 1035-1047.
  • 5Yang JC, Haworth L, Sherry RM, Hwu P, Slhwartzentruber D J, Topalian S, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer [ J ]. N Engl J Med 2003 ;349 (5) :427-434.
  • 6Spaide RF, Laud -K, Fine HF. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration[J].Retina 2005 ;25(4) :383-390.
  • 7Rosenfeld PJ,Moshfeghi AA,Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration [J]. Ophthalmic Surg Lasers Imaging 2005 ;36(4) :331-335.
  • 8Avery RL,Pieramici DJ,Rabena MD,Castellarin AA,Nasir MA, Giust MJ. Intravitreal bevacizumab ( Avastin ) for neovascular age-related macular degeneration [J].Ophthalmology 2006 ; 113 (3) :363-372.
  • 9Spaide RF, Fisher YL. Intravitreal bevacizumab ( Avastin ) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage [ J ]. Retina 2006 ;25 ( 3 ) :275-278.
  • 10Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study[J]. Retina 2006 ; 26 ( 3 ) : 279-284.

共引文献18

同被引文献101

引证文献10

二级引证文献46

眼科新进展
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部